- Home
- ATRI
ATRI
Atrion Corporation
as 07-26-2024 4:00pm EST
Atrion Corp develops and manufactures products for medical applications. Its fluid-delivery products contribute the largest proportion of revenue and include valves that can hold and release controlled amounts of fluids or gases and are often used in anesthesia and oncology applications. Atrion's cardiovascular products include the MPS2 Myocardial Protection System, which delivers fluids and medications, mixes drugs, and controls temperature and pressure during open-heart surgery. The cardiovascular business also sells cardiac-surgery vacuum relief valves, inflation devices, and other products used in heart surgery. The firm's ophthalmic products include medical devices that disinfect contact lenses. Atrion generates the majority of revenue in the United States.
| Founded: | 1944 | Country: | United States |
| Employees: | N/A | City: | ALLEN |
| Market Cap: | 795.5M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 26.2K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 10.64 | EPS Growth: | -36.74 |
| 52 Week Low/High: | $274.98 - $575.88 | Next Earning Date: | 08-06-2024 |
| Revenue: | $176,667,000 | Revenue Growth: | 0.17% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Atrion Corporation (ATRI)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Athey Preston G | ATRI | Director | Dec 1 '23 | Buy | $319.68 | 300 | $95,904.00 | 1,368 | SEC Form 4 |
Latest Atrion Corporation News
ATRI Breaking Stock News: Dive into ATRI Ticker-Specific Updates for Smart Investing
Zacks
17 days ago
The Zacks Analyst Blog Highlights Advanced Micro Devices, GE Aerospace, Newmont and Atrion
Simply Wall St.
23 days ago
Investors in Atrion (NASDAQ:ATRI) have unfortunately lost 38% over the last five years
Zacks
2 months ago
Zacks Initiates Coverage of Atrion With Neutral Recommendation
Zacks
2 months ago
The Zacks Analyst Blog Highlights JPMorganChase, Chevron, Cisco Systems, Atrion and The Eastern
Zacks
2 months ago
Top Analyst Reports for JPMorgan Chase, Chevron & Cisco
Zacks
2 months ago
Nordson (NDSN) to Acquire Atrion & Boost Medical Offerings
Zacks
2 months ago
Nordson (NDSN) to Acquire Atrion & Boost Medical Offerings
MT Newswires
2 months ago
Nordson to Acquire Atrion for $460 Per Share in Cash
Compare ATRI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ATRI Atrion Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.